JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 40:1777-1785
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen Maycock, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen Maycock, C. A.

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients

Chloe A. Allen Maycock, RN, BSN*, Joseph B. Muhlestein, MD, FACC*{dagger},*, Benjamin D. Horne, MPH*, John F. Carlquist, PhD*{dagger}, Tami L. Bair, BS*, Robert R. Pearson, BS*, Qunyu Li, MD*, Jeffrey L. Anderson, MD, FACC*{dagger} Intermountain Heart Collaborative Study

* LDS Hospital, Salt Lake City, Utah, USA
{dagger} University of Utah, Salt Lake City, Utah, USA



View larger version (20K):

[in a new window]
 
Figure 1 Bar graph of mortality for patients using statins (open bars) and not using statins (solid bars) by age groups.

 



View larger version (35K):

[in a new window]
 
Figure 2 Univariate Kaplan-Meier survival curves for statin users and nonusers among three age groups: (A) younger patients <65 years old; (B) older patients 65 to 79 years old; and (C) very elderly patients 80 years of age or older. Continued on next page.

 



View larger version (36K):

[in a new window]
 
Figure 3 Multivariate adjusted Kaplan-Meier survival curves for statin users and nonusers among the age groups: (A) younger patients <65 years old; (B) older patients 65 to 79 years old; and (C) very elderly patients 80 years of age or older. Although the absolute survival rates differed substantially across the age groups, statins had clinically profound benefits for all age groups of patients with coronary artery disease. HR = hazard ratio. Continued on next page.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.